4.175
Salarius Pharmaceuticals Inc Aktie (SLRX) Neueste Nachrichten
Salarius Pharma Stock Jumps After-Hours As Nasdaq Compliance Clears Path For Decoy Merger — Retail Bulls Bet On Breakout - Stocktwits
Salarius Pharmaceuticals Regains Nasdaq Compliance - TradingView
Applying Elliott Wave Theory to Salarius Pharmaceuticals Inc.2025 Trading Recap & Capital Efficiency Focused Ideas - newser.com
Will Salarius Pharmaceuticals Inc. stock benefit from green energy trendsWall Street Watch & Safe Swing Trade Setups - newser.com
How institutional ownership impacts Salarius Pharmaceuticals Inc. stockRate Hike & Weekly High Conviction Ideas - newser.com
Intraday pattern recognizer results for Salarius Pharmaceuticals Inc.July 2025 Trade Ideas & AI Based Buy and Sell Signals - newser.com
How higher bond yields impact Salarius Pharmaceuticals Inc. (FP10) stockCPI Data & Weekly Setup with High ROI Potential - newser.com
How to recover losses in Salarius Pharmaceuticals Inc. stock2025 Price Momentum & Low Drawdown Investment Ideas - newser.com
Can machine learning forecast Salarius Pharmaceuticals Inc. recoveryPortfolio Update Report & Precise Buy Zone Identification - newser.com
Real time alert setup for Salarius Pharmaceuticals Inc. performanceRisk Management & Verified Technical Signals - newser.com
Salarius Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements Ahead of Merger with Decoy Therapeutics - Quiver Quantitative
Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements - GlobeNewswire
Can Salarius Pharmaceuticals Inc. stock deliver sustainable ROETrade Volume Report & Weekly Return Optimization Alerts - newser.com
Salarius Pharmaceuticals Inc. stock momentum explainedTrade Ideas & Expert Curated Trade Ideas - newser.com
Long term hold vs stop loss in Salarius Pharmaceuticals Inc.July 2025 Catalysts & Weekly Momentum Picks - newser.com
What data driven models say about Salarius Pharmaceuticals Inc.’s futureJuly 2025 Big Picture & Low Drawdown Investment Ideas - newser.com
Is Salarius Pharmaceuticals Inc. (FP10) stock positioned for secular growth2025 Risk Factors & Consistent Profit Trading Strategies - newser.com
Why Salarius Pharmaceuticals Inc. (FP10) stock could break out in 2025Quarterly Market Review & Momentum Based Trading Signals - newser.com
Ewing Sarcoma Market Report 2034: Epidemiology Insights, Pipeline Developments, and Key Regulatory Approvals (FDA, EMA, PMDA) | Published by DelveInsight | Featuring Leading Companies: Salarius Pharma - Barchart.com
Salarius Pharmaceuticals (NASDAQ:SLRX) Trading 1% Higher – Here’s Why - Defense World
Salarius Pharmaceuticals Awaits Nasdaq Compliance Confirmation - TipRanks
What Fibonacci levels say about Salarius Pharmaceuticals Inc. reboundQuarterly Trade Review & Capital Efficient Trade Techniques - newser.com
Exit strategy if you’re trapped in Salarius Pharmaceuticals Inc.Market Movers & Daily Volume Surge Trade Alerts - newser.com
Risk vs reward if holding onto Salarius Pharmaceuticals Inc.July 2025 Technicals & Safe Entry Trade Reports - newser.com
Is Salarius Pharmaceuticals Inc. building a consolidation baseWeekly Stock Recap & Technical Buy Zone Confirmations - newser.com
Should you wait for a breakout in Salarius Pharmaceuticals Inc.2025 Market Outlook & Safe Capital Growth Tips - newser.com
What momentum shifts mean for Salarius Pharmaceuticals Inc.2025 Price Action Summary & Weekly Chart Analysis and Trade Guides - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):